To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder	Recruiting	Phase 3	2025-12-09		NCT06833983

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Gritgen Therapeutics Co., Ltd.	3

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Anhui Provincial Hospital	Hefei	China	32
Central Hospital Affiliated to Shandong First Medical University	Jinan	China	8
First Hospital of Lanzhou University	Lanzhou	China	1
Henan Cancer Hospital	Zhengzhou	China	57
Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College	Tianjin	China	4
Jiangxi Provincial People's Hospital	Nanchang	China	1
Nanfang Hospital Southern Medical University	Guangzhou	China	8
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School	Nanjing	China	2
North China University of Science and Technology Affiliated Hospital	Tangshan	China	7
Peking Union Medical College Hospital	Beijing	China	19
The Second Affiliated Hospital of Kunming Medical University	Kunming	China	6
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	77
Xiangya Hospital of Central South University	Changsha	China	3